Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value - PubMed (original) (raw)
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value
Siri Tveito et al. Clin Exp Metastasis. 2007.
Abstract
Molecular studies of rare cells, such as circulating cancer cells, require efficient pre-enrichment steps to obtain a pure population of target cells for further characterization. We have developed a two-step approach, starting with immunomagnetic enrichment, followed by specific isolation of individual, easily identifiable bead-rosetted target cells using a new semi-automated CellPick system. With this procedure, 1-50 live target cells can now be isolated. As a model system, we spiked a small number of tumor cells into millions of normal mononuclear cells (MNCs). Efficient isolation of pure target cells was obtained by use of the CellPick system, and the nature of isolated, bead-rosetted cells was verified by use of FISH. Single breast cancer cells were picked directly into an RNA preserving lysis buffer, reverse transcribed, and PCR amplified with two cDNA specific primer sets. With the isolated cells we consistently obtained both ubiquitously expressed and tumor cell specific PCR products. We also performed a successful mutation analysis of single cells using PCR and cycling temperature capillary electrophoresis (CTCE). This may have significant clinical implications in cancer and in other diseases, e.g. in characterizing micrometastatic cancer cells in blood and lymph nodes to help identifying patients who most likely will respond to therapies like tyrosine kinase inhibitors and compounds targeting specific mutations. By use of the CellPick system it is possible to specifically isolate bead-rosetted or otherwise labelled target cells from a heterogeneous cell population for further molecular characterization.
Similar articles
- Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.
Laget S, Broncy L, Hormigos K, Dhingra DM, BenMohamed F, Capiod T, Osteras M, Farinelli L, Jackson S, Paterlini-Bréchot P. Laget S, et al. PLoS One. 2017 Jan 6;12(1):e0169427. doi: 10.1371/journal.pone.0169427. eCollection 2017. PLoS One. 2017. PMID: 28060956 Free PMC article. - Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells.
Beasley AB, Acheampong E, Lin W, Gray ES. Beasley AB, et al. Methods Mol Biol. 2021;2265:213-222. doi: 10.1007/978-1-0716-1205-7_16. Methods Mol Biol. 2021. PMID: 33704717 - Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X, Yang L, Lang JC, Zborowski M, Chalmers JJ. Tong X, et al. Cytometry B Clin Cytom. 2007 Sep;72(5):310-23. doi: 10.1002/cyto.b.20177. Cytometry B Clin Cytom. 2007. PMID: 17205568 - Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
Ghossein RA, Carusone L, Bhattacharya S. Ghossein RA, et al. In Vivo. 2000 Jan-Feb;14(1):237-50. In Vivo. 2000. PMID: 10757082 Review. - Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.
Ghossein RA, Bhattacharya S. Ghossein RA, et al. Eur J Cancer. 2000 Aug;36(13 Spec No):1681-94. doi: 10.1016/s0959-8049(00)00152-0. Eur J Cancer. 2000. PMID: 10959054 Review.
Cited by
- Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.
Gaikwad H, Li Y, Gifford G, Groman E, Banda NK, Saba L, Scheinman R, Wang G, Simberg D. Gaikwad H, et al. Bioconjug Chem. 2020 Jul 15;31(7):1844-1856. doi: 10.1021/acs.bioconjchem.0c00342. Epub 2020 Jun 29. Bioconjug Chem. 2020. PMID: 32598839 Free PMC article. - Efficacy and feasibility of the epithelial cell adhesion molecule (EpCAM) immunomagnetic cell sorter for studies of DNA methylation in colorectal cancer.
Failli A, Legitimo A, Migheli F, Coppedè F, Mathers JC, Spisni R, Miccoli P, Migliore L, Consolini R. Failli A, et al. Int J Mol Sci. 2013 Dec 20;15(1):44-57. doi: 10.3390/ijms15010044. Int J Mol Sci. 2013. PMID: 24362576 Free PMC article. - Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles.
Shi G, Cui W, Mukthavaram R, Liu YT, Simberg D. Shi G, et al. Methods. 2013 Dec 1;64(2):102-7. doi: 10.1016/j.ymeth.2013.08.008. Epub 2013 Aug 22. Methods. 2013. PMID: 23974072 Free PMC article. - Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles.
Shi G, Cui W, Benchimol M, Liu YT, Mattrey RF, Mukthavaram R, Kesari S, Esener SC, Simberg D. Shi G, et al. PLoS One. 2013;8(3):e58017. doi: 10.1371/journal.pone.0058017. Epub 2013 Mar 13. PLoS One. 2013. PMID: 23516425 Free PMC article. - Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E. Hjortland GO, et al. BMC Cancer. 2011 Oct 20;11:455. doi: 10.1186/1471-2407-11-455. BMC Cancer. 2011. PMID: 22014070 Free PMC article.
References
- J Surg Oncol. 2003 Apr;82(4):224-7 - PubMed
- Lancet. 1996 Mar 9;347(9002):649-53 - PubMed
- J Clin Oncol. 2003 Sep 15;21(18):3469-78 - PubMed
- Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4134-9 - PubMed
- Nat Genet. 2003 Jan;33(1):49-54 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials